Jee Eun Chung

Prof. Dr. Jee Eun Chung

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
SHSunghee Hwang
Sunghee Hwang
KJKwanghee Jun
Kwanghee Jun
YAYoung-Mi Ah
Young-Mi Ah
EHEuna Han
Euna Han
JCJee Eun Chung
Jee Eun Chung
JLJuyeun Lee
Juyeun Lee

Verified
Journal Article
Open access
PDF file
JKJin-Woo Kim
Jin-Woo Kim
JYJeong Yee
Jeong Yee
SOSang-Hyeon Oh
Sang-Hyeon Oh
SKSun-Hyun Kim
Sun-Hyun Kim
SKSun-Jong Kim
Sun-Jong Kim
Hye Sun GwakHye Sun Gwak
Hye Sun Gwak
Objective: This nested case–control study aimed to investigate the effects of VEGFA polymorphisms on the development of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in women with osteoporosis. Methods: Eleven single nucleotide polymorphisms (SNPs) of the VEGFA were assessed in a total of 125 patients. Logistic regression was performed for multivariable analysis. Machine learning algorithms, namely, fivefold cross-validated multivariate logistic regression, elastic net, random forest, and support vector machine, were developed to predict risk factors for BRONJ occurrence. Area under the receiver-operating curve (AUROC) analysis was conducted to assess clinical performance. Results: The VEGFA rs881858 was significantly associated with BRONJ development. The odds of BRONJ development were 6.45 times (95% CI, 1.69–24.65) higher among carriers of the wild-type rs881858 allele compared with variant homozygote carriers after adjusting for covariates. Additionally, variant homozygote (GG) carriers of rs10434 had higher odds than those with wild-type allele (OR, 3.16). Age ≥ 65 years (OR, 16.05) and bisphosphonate exposure ≥ 36 months (OR, 3.67) were also significant risk factors for BRONJ occurrence. AUROC values were higher than 0.78 for all machine learning methods employed in this study. Conclusion: Our study showed that the BRONJ occurrence was associated with VEGFA polymorphisms in osteoporotic women.

4 August 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SCSeunghyun Cheon
Seunghyun Cheon
JKJung Suk Kim
Jung Suk Kim
MWMi Ran Woo
Mi Ran Woo
SJSang Hun Ji
Sang Hun Ji
SPSeonghyeon Park
Seonghyeon Park
HCHan-Gon Choi
Han-Gon Choi

23 August 2024 in Asian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
JKJung Suk Kim
Jung Suk Kim
SCSeunghyun Cheon
Seunghyun Cheon
MWMi Ran Woo
Mi Ran Woo
SWSanghyun Woo
Sanghyun Woo
JCJee Eun Chung
Jee Eun Chung
HCHan-Gon Choi
Han-Gon Choi
While spray-drying has been widely utilized to improve the bioavailability of poorly water-soluble drugs, the outcomes often exhibit suboptimal particle size distribution and large particle sizes, limiting their effectiveness. In this study, we introduce electrostatic spraying as an advanced technology tailored for poorly water-soluble drugs, enabling the fabrication of nanoparticles with fine and uniform particle size distribution. Regorafenib (1 g), as a model drug, copovidone (5 g), and sodium dodecyl sulfate (0.1 g) were dissolved in 200 ml ethanol and subjected to conventional-spray-dryer and electrostatic spray dryer. The electrostatic spray-dried nanoparticles (ESDN) showed smaller particle sizes with better uniformity compared to conventional spray-dried nanoparticles (CSDN). ESDN demonstrated significantly enhanced solubility and rapid release in water. In vitro studies revealed that ESDN induced apoptosis in HCT-116 cells to a greater extent, exhibiting superior cytotoxicity compared to CSDN. Furthermore, ESDN substantially improved oral bioavailability and antitumor efficacy compared to CSDN. These findings suggest that ESD shows potential in developing enhanced drug delivery systems for poorly water-soluble drugs, effectively addressing the limitations associated with CSD methods.

24 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KLKyung Eun Lee
Kyung Eun Lee
JYJeong Yee
Jeong Yee
GLGwan Yung Lee
Gwan Yung Lee
JCJee Eun Chung
Jee Eun Chung
JSJong Mi Seong
Jong Mi Seong
Hye Sun GwakHye Sun Gwak
Hye Sun Gwak
This prospective, single-blind, randomized study was designed to evaluate the effect of genotype-based warfarin dosing compared with standard warfarin dosing in Korean patients with mechanical cardiac valves. Patients were assigned to either the genotype-based dosing group or the standard dosing group using stratified block randomization. The genotype-based dosing equation was adopted from a previous study which included VKORC1 rs9934438, CYP2C9 rs1057910, CYP4F2 rs2108622, and age. Primary outcomes included the percentage of time in the therapeutic range (pTTR): (i) during the first week following initiation of warfarin therapy, (ii) during hospitalization and (iii) until the first outpatient visit. A total of 91 patients were included in the analysis, 42 treated with genotype-based warfarin dosing and 49 treated with standard warfarin dosing. The genotype frequency differences of the three SNPs included in this study (ie, VKORC1, CYP2C9, CYP4F2), between the genotype-based dosing and standard dosing groups were not different. The genotype-based dosing group trended toward higher pTTR when compared with the standard dosing group, although this difference was not statistically significant. In patients with aortic valve replacement, TTRTraditional and TTRRosendaal were significantly higher in the genotype-based dosing group when compared with the standard dosing group during the first week following treatment initiation [ie, 58.5% vs. 38.1% (p = 0.009) and 64.0% vs. 44.6% (p = 0.012), respectively]. Based on the results, the genotype-guided dosing did not offer a significant clinical advantage, but a possible benefit in patients with aortic valve replacement has been suggested.

29 May 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
SCSeunghyun Cheon
Seunghyun Cheon
SOSang-Hyeon Oh
Sang-Hyeon Oh
JKJung-Tae Kim
Jung-Tae Kim
HCHan-Gon Choi
Han-Gon Choi
HPHyo Jung Park
Hyo Jung Park
JCJee Eun Chung
Jee Eun Chung
This study aimed to investigate the activity of a nutrition support team (NST) and the trends of multi-chamber bag (MCB) and customized parenteral nutrition (PN) with NST consultations in South Korea. Data were obtained from the National Inpatient Sample Cohort between 2015 and 2020. Three datasets were constructed for NST consultation, MCB-PN product prescriptions, and aseptic preparation of total PN. The intersections of the NST consultation and each PN dataset were compiled into MCB-PN with NST or customized PN with a NST sub-dataset, respectively. Using personal identifiers, the patients’ characteristics were evaluated in the NST cohort. A total of 91,384 reimbursements and 70,665 patients were included. The NST activity had increased by more than 50% over 6 years. Approximately 70% and 11%, respectively, of the NST cohort were classified into two subgroups: MCB-PN with NST (M-NST) and customized PN with NST (C-NST). M-NST had many elderly patients with cancer and showed a higher in-hospital mortality than C-NST (12.6% vs. 9.5%). C-NST included a larger number of patients under the age of 5 years, and the hospitalization period was more extended than M-NST (26.2 vs. 21.2 days). The present study showed that NST activities and the proportion of PN with NST consultation are gradually increasing in South Korea.